Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Merck
Baxter
Queensland Health
Medtronic
Federal Trade Commission
McKinsey
Daiichi Sankyo
QuintilesIMS
Cipla

Generated: August 18, 2017

DrugPatentWatch Database Preview

Clevidipine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clevidipine and what is the scope of clevidipine patent protection?

Clevidipine
is the generic ingredient in one branded drug marketed by Chiesi Usa Inc and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Clevidipine has fifty-eight patent family members in thirty-three countries.

There are three drug master file entries for clevidipine. Three suppliers are listed for this compound.

Summary for Generic Name: clevidipine

Tradenames:1
Patents:2
Applicants:1
NDAs:1
Drug Master File Entries: see list3
Suppliers / Packagers: see list3
Bulk Api Vendors: see list51
Clinical Trials: see list19
Patent Applications: see list726
Drug Prices:see low prices
DailyMed Link:clevidipine at DailyMed

Pharmacology for Ingredient: clevidipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa Inc
CLEVIPREX
clevidipine
EMULSION;INTRAVENOUS022156-001Aug 1, 2008RXYesYes► Subscribe► SubscribeYY ► Subscribe
Chiesi Usa Inc
CLEVIPREX
clevidipine
EMULSION;INTRAVENOUS022156-002Aug 1, 2008RXYesYes► Subscribe► SubscribeYY ► Subscribe
Chiesi Usa Inc
CLEVIPREX
clevidipine
EMULSION;INTRAVENOUS022156-003Nov 8, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
Chiesi Usa Inc
CLEVIPREX
clevidipine
EMULSION;INTRAVENOUS022156-003Nov 8, 2013RXYesYes► Subscribe► SubscribeYY ► Subscribe
Chiesi Usa Inc
CLEVIPREX
clevidipine
EMULSION;INTRAVENOUS022156-001Aug 1, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: clevidipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chiesi Usa Inc
CLEVIPREX
clevidipine
EMULSION;INTRAVENOUS022156-001Aug 1, 2008► Subscribe► Subscribe
Chiesi Usa Inc
CLEVIPREX
clevidipine
EMULSION;INTRAVENOUS022156-002Aug 1, 2008► Subscribe► Subscribe
Chiesi Usa Inc
CLEVIPREX
clevidipine
EMULSION;INTRAVENOUS022156-003Nov 8, 2013► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: clevidipine

Country Document Number Estimated Expiration
Iceland1674► Subscribe
Hong Kong1187495► Subscribe
Czech Republic285691► Subscribe
Portugal2627173► Subscribe
Finland961914► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: CLEVIDIPINE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90008-0Sweden► SubscribePRODUCT NAME: CLEVIDIPINE; NAT. REG. NO/DATE: 42321 20120120; FIRST REG.: GB PL 16881/0003 20111123
C0053France► SubscribePRODUCT NAME: CLEVIDIPINE; NAT. REGISTRATION NO/DATE: NL 37621 20120725; FIRST REGISTRATION: GB - PL 16881/0003 20111123
209Luxembourg► SubscribePRODUCT NAME: CLEVIDIPINE SOUS TOUTES LES FORMES PROCURANT UNE PROTECTION A PARTIR DU BREVET DE BASE
C/GB12/011United Kingdom► SubscribePRODUCT NAME: CLEVIDIPINE; REGISTERED: UK PL16881/0003 20111123
00520Netherlands► SubscribePRODUCT NAME: CLEVIDIPINE; NAT. REGISTRATION NO/DATE: RVG 104771 20111129; FIRST REGISTRATION: PL 16881/0003 20111123
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Baxter
Johnson and Johnson
US Department of Justice
Queensland Health
AstraZeneca
Fish and Richardson
Moodys
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot